Saturday, October 3, 2026

EUR/CHF Over 1% Down In The Last 21 Sessions

EUR/CHF Over 1% Down In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.85% for the last 21 sessions. At 09:07 EST on Tuesday, 25 July, EUR/CHF (EURCHF) is $0.96.

EUR/CHF's yearly highs and lows, it's 1.686% up from its 52-week low and 5.041% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.09%, a negative 0.11%, and a positive 0.22%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.23% (last week), 0.20% (last month), and 0.22% (last quarter), respectively.

News about

  • Usd/jpy May turn lower in the event boj surprises on Friday – OCBC. According to FXStreet on Monday, 24 July, "In the event BoJ surprises on Friday, then we may see USD/JPY turn lower as markets may be caught wrongfooted."
  • Usd/jpy pulls back from two-week high, trades with modest losses below mid-141.00s. According to FXStreet on Monday, 24 July, "This revives hopes that the BoJ might tweak its Yield Curve Control (YCC) policy later this week, which, along with a softer risk tone, underpins the safe-haven JPY and act as a headwind for the USD/JPY pair.", "Apart from this, the broader risk sentiment might also contribute to producing short-term opportunities around the USD/JPY pair."
  • Usd/jpy consolidates above the 141.40 area, investors await the US CB consumer confidence. According to FXStreet on Tuesday, 25 July, "The monetary policy divergence between the BoJ and Fed might exert pressure on the Japanese Yen against its major rivals and could be a headwind for the USD/JPY pair. ", "Traders will take cues from the data and find opportunities around the USD/JPY pair."
  • Usd/jpy technical analysis: central bank policies determine the fate - 24 July 2023. According to DailyForex on Monday, 24 July, "According to the fundamental analysis, the USD/JPY currency pair is trading affected by the results of the recent economic data, as the Japanese National Consumer Price Index for June missed the expected change (yearly) by 3.5% with a change of 3.3%. ", "Last Thursday, US initial jobless claims for the week ending July 14 exceeded the expected claims count of 245,000 with a count of 228,000, while continuing claims for the prior period topped 1.729 million with a claims count of 1.754 million.USD/JPY Technical OutlookThe price of the USD/JPY currency pair has now advanced to trade a few levels above the 100-hour moving average line. "

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com